| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NXDT | 5.50% Series A Cumulative Preferred Shares | Purchase | $33.6K | +2.2K | +16.93% | $15.24 | 15.2K | May 18, 2023 | See Footnote | F1 |
| transaction | NXDT | 5.50% Series A Cumulative Preferred Shares | Purchase | $3.13K | +205 | +1.35% | $15.25 | 15.4K | May 19, 2023 | See Footnote | F1 |
| transaction | NXDT | Common Stock | Purchase | $82.6K | +8.56K | +3.54% | $9.65 | 250K | May 18, 2023 | See Footnote | F4 |
| transaction | NXDT | Common Stock | Purchase | $48.7K | +5.02K | +2.01% | $9.70 | 255K | May 18, 2023 | See Footnote | F4 |
| transaction | NXDT | Common Stock | Purchase | $143K | +14.4K | +5.66% | $9.91 | 270K | May 19, 2023 | See Footnote | F4 |
| holding | NXDT | 5.50% Series A Cumulative Preferred Shares | 46K | May 18, 2023 | See Footnote | F2 | |||||
| holding | NXDT | 5.50% Series A Cumulative Preferred Shares | 16K | May 18, 2023 | See Footnote | F3 | |||||
| holding | NXDT | Common Stock | 1.83M | May 18, 2023 | See Footnote | F5 | |||||
| holding | NXDT | Common Stock | 89.1K | May 18, 2023 | Direct | F6 | |||||
| holding | NXDT | Common Stock | 3.96M | May 18, 2023 | See Footnote | F2, F6 | |||||
| holding | NXDT | Common Stock | 514K | May 18, 2023 | See Footnote | F7 | |||||
| holding | NXDT | Common Stock | 62.8K | May 18, 2023 | By employee benefit plan | F6 |
| Id | Content |
|---|---|
| F1 | These shares are held by Drugcrafters, L.P. ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F2 | These shares are held by The Dugaboy Investment Trust of which Mr. Dondero is the beneficiary pursuant to an employee purchase plan. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F3 | These shares are held by Highland Global Allocation Fund, which is managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management"). Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of shares held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F4 | 28,011 shares are held by Drugcrafters, 65,714.39 shares are held by PCMG Trading Partners XXIII, L.P. and 175,780 shares are held by Governance Re Ltd. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F5 | 1,275,616 shares are held by Highland Income Fund and 549,863 shares are held by Highland Global Allocation Fund. These entities are managed by NexPoint Asset Management, which is ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F6 | Includes shares acquired under a dividend reinvestment plan. |
| F7 | These shares are held by subsidiaries of The Dugaboy Investment Trust. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
President